早期Trifecta瓣膜失败:一家三级转诊中心的病例集群报告
该病例系列报告了7例患者共8枚Trifecta瓣膜早期失败,平均耐久时间32±21个月,最常见表现为人工瓣膜反流和心力衰竭加重。再干预时平均STS风险评分为9.75%±8.1%,5例再次外科换瓣、2例瓣中瓣TAVR、1例术前死亡。病理常见流入道纤维脂肪性环形血管翳,以及流出道瓣柱周围钙化。
要点
- Trifecta瓣膜早期失败可表现为反流,平均耐久时间约32个月。
- 再干预前常有心力衰竭加重,STS风险评分较高。
- 环形血管翳和瓣柱周围钙化是重要失败机制。
核心结论
- 除文献报道的无冠瓣撕裂外,流入道纤维脂肪性环形血管翳和流出道瓣柱周围钙化也是Trifecta瓣膜早期失败的重要机制。
研究设计与样本
- 单中心病例系列,纳入7例患者共8枚失败的Trifecta瓣膜,描述临床特征、管理和病理。
主要发现
- 瓣膜尺寸包括19-mm(n=2)、21-mm(n=3)、23-mm(n=1)和25-mm(n=2),平均耐久时间32±21个月。
- 最常见病变为人工瓣膜反流,再干预时平均STS死亡风险评分9.75%±8.1%。
- 心力衰竭加重是最常见就诊症状;5例再次外科主动脉瓣置换,2例瓣中瓣经导管主动脉瓣置换,1例再干预前死于心源性休克。
- 切除瓣膜最常见病理为附着于流入道的黄褐色纤维脂肪性环形血管翳。
临床怎么用
- 对Trifecta瓣膜植入后出现心力衰竭加重或反流的患者,应警惕早期瓣膜失败并及时评估再干预。
- 再干预决策需考虑较高的STS风险评分,并识别血管翳和钙化等病理机制。
局限性
- 单中心病例系列,样本量小(7例患者8枚瓣膜),未设对照,不能推断发生率或因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Trifecta valve (St Jude Medical, Inc, St Paul, Minn) was approved for commercial use by the US Food and Drug Administration in 2011. Several isolated cases have been reported since then, describing early structural valve deterioration. We report a case series of 8 Trifecta valve failures, describing patients' clinical substrate and management, and the pathologic characteristics of the explanted valves. METHODS: Trifecta valve failure occurred in 7 patients (8 valves) receiving 19-mm (n = 2), 21-mm (n = 3), 23-mm (n = 1), and 25-mm (n = 2) valves. The mean duration of valve durability was 32 ± 21 months, and the most common lesion was prosthetic regurgitation. The mean Society of Thoracic Surgeons risk score for perioperative mortality at the time of reintervention was 9.75% ± 8.1%. Heart failure exacerbation was the most common presenting symptom. RESULTS: Five patients underwent surgical aortic valve replacement, 2 patients received valve-in-valve transcatheter aortic valve replacement, and 1 patient died of cardiogenic shock before reintervention. The most common pathologic finding in the explanted valves was a tan-yellow fibrofatty circumferential pannus adherent to the inflow portion of the Trifecta valve. CONCLUSIONS: Our findings provide further insights into the pathologic mechanisms leading to early Trifecta valve failure. In addition to tear of the noncoronary cusp of the Trifecta prosthesis described as the most common mechanism in the literature for its failure, circumferential pannus formation composed of fibrofatty tissue in the inflow portion and leaflet calcification concentrated around the posts in the outflow portion are important mechanisms contributing toward early Trifecta valve failure.
引用
- Kalra A, Rehman H, Ramchandani M, et al. Early Trifecta valve failure: Report of a cluster of cases from a tertiary care referral center. J Thorac Cardiovasc Surg. 2017. PMID: 28610762. doi:10.1016/j.jtcvs.2017.05.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。